Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma-Reference-Cited by-同舟云学术

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

Published:2019-03 Issue:3 Volume:143 Page:970-977
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Pfaar Oliver,Bachert Claus,Kuna Piotr,Panzner Petr,Džupinová Mária,Klimek Ludger,van Nimwegen Maroesja J.,Boot Johan D.,Yu Donghui,Opstelten Dirk Jan E.,de Kam Pieter-Jan

Funder

HAL Allergy B.V.

ALK-Abelló

Allergopharma

Stallergenes Greer

Bencard Allergie GmbH

Lofarma

Biomay

Nuvo

Circassia

Biotech Tools S.A.

Laboratorios LETI

Anergis S.A.

GlaxoSmithKline

HAL

Biotech Tools

Novartis Pharma

Mylan

Sanofi Aventis

AstraZeneca

Novartis

Bionorica

GlaxoSmithKlinea

LETI

Roxall

Bencard

HAL Allergy B.V., Leiden, The Netherlands

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen);Bousquet;Allergy,2008

2. A survey of the burden of allergic rhinitis in Europe;Canonica;Allergy,2007

3. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report;Bacharier;Allergy,2008

4. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study;Burgess;J Allergy Clin Immunol,2007

5. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study;Schmitt;J Allergy Clin Immunol,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance;Allergy;2024-07-28

2. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

3. Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis;Clinical and Translational Allergy;2023-12

4. A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids;Allergy;2023-10-12

5. Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study;Journal of Clinical Medicine;2023-08-25